Neuronetics Announces the Appointment of Keith J. Sullivan as President and Chief Executive Officer
Keith’s track record includes successfully growing multiple MedTech businesses, driving innovation and impressive market development
We believe that Keith’s experience in commercializing products that involve both capital equipment and recurring revenue streams is an excellent fit with Neuronetics, and I am confident his public company experience and leadership skills further position Neuronetics extremely well for strong execution
Mr. Sullivan brings over three decades of medical device industry experience to the company
Mr. Sullivan, who has more than 30 years of senior sales leadership experience in the medical device industry
Mr. Sullivan received a Bachelor of Business Administration from the College of William and Mary and is a clinical professor in the Mason School of Business at William and Mary.
globenewswire.com/news-release/2020/07/14/2062184/0/en/Neuronetics-Announces-the-Appointment-of-Keith-J-Sullivan-as-President-and-Chief-Executive-Officer.html
Keith’s track record includes successfully growing multiple MedTech businesses, driving innovation and impressive market development
We believe that Keith’s experience in commercializing products that involve both capital equipment and recurring revenue streams is an excellent fit with Neuronetics, and I am confident his public company experience and leadership skills further position Neuronetics extremely well for strong execution
Mr. Sullivan brings over three decades of medical device industry experience to the company
Mr. Sullivan, who has more than 30 years of senior sales leadership experience in the medical device industry
Mr. Sullivan received a Bachelor of Business Administration from the College of William and Mary and is a clinical professor in the Mason School of Business at William and Mary.
globenewswire.com/news-release/2020/07/14/2062184/0/en/Neuronetics-Announces-the-Appointment-of-Keith-J-Sullivan-as-President-and-Chief-Executive-Officer.html
כתב ויתור
המידע והפרסומים אינם מיועדים להיות, ואינם מהווים, ייעוץ או המלצה פיננסית, השקעתית, מסחרית או מכל סוג אחר המסופקת או מאושרת על ידי TradingView. קרא עוד ב־תנאי השימוש.
כתב ויתור
המידע והפרסומים אינם מיועדים להיות, ואינם מהווים, ייעוץ או המלצה פיננסית, השקעתית, מסחרית או מכל סוג אחר המסופקת או מאושרת על ידי TradingView. קרא עוד ב־תנאי השימוש.